Search clinical trials for: (G) BQ-L14

Total 3994 results

ORIC Pharmaceuticals

Completed

Effect of Food on the Pharmacokinetics of ORIC-114

Food Effect in Healthy Participants

Australia
Bruce J Gantz

Completed

Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants

Child | Hearing Loss, Bilateral | Implants, Cochlear

United States
Caliway Biopharmaceuticals Co., Ltd.

Completed

A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat

Subcutaneous Fat

Australia
Fusion Pharma LLC
Data Matrix Solutions; OCT Rus, LLC; Skolkovo Innovation Center

Unknown

Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene

Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Chronic Myeloid Leukemia

Russian Federation
AbbVie

No longer available

Expanded Access to ABT-414

Glioblastoma or Solid Tumors, Epidermal Growth Factor Receptor (EGFR) Diagnosis
Sunesis Pharmaceuticals

Completed

Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors

Advanced Solid Tumors

United States
Abbott

Completed

Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain

Healthy Volunteers

Canada
Abbott

Completed

A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans

Healthy

United States
Amgen

Terminated

A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy

Cancer | Anemia
ImmPACT Bio

Recruiting

Study of IMPT-314 in R/R Aggressive B-cell NHL

Refractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin Lymphoma

United States
Amgen

Available

AMG 714 Expanded Access Program

Celiac Disease
AbbVie
AbbVie

Enrolling by invitation

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy (RGX-314 SRLTFU)

Wet Macular Degeneration | Neovascular Age-related Macular Degeneration

United States
REGENXBIO Inc.

Completed

Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial

Neovascular Age-related Macular Degeneration | Wet Age-related Macular Degeneration

United States
Maastricht Radiation Oncology

Completed

Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor (L19-IL2)

Solid Tumour

Netherlands
Postgraduate Institute of Medical Education and...

Completed

Granulocyte Colony Stimulating Factor Four Week Plus N-Acetyl Cysteine in Severe Alcoholic Hepatitis

Alcoholic Hepatitis

India
Beike Biotech India Pvt.ltd

Unknown

A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia

Diabetic Foot | Critical Limb Ischemia | Leg Ulcers

India
University of Reading
Tufts University; California Walnut Commission

Completed

The Acute Effect of a Walnut Intervention on Cognitive Performance, Brain Activation, and Serum Markers of Inflammation in Young Adults (WalCog)

Cognitive Change | Inflammatory Response | Mood | Satiety | Brain Derived Neurotrophic Factor Level

United Kingdom
Chinese University of Hong Kong

Completed

Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule

Peripheral Arterial Disease | Intermittent Claudication

Hong Kong
Pfizer

Completed

This Study Is To Estimate The Time Course Of Pf-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers

Healthy

Singapore
Memorial Sloan Kettering Cancer Center

Terminated

Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors

Acute Myeloid Leukemia (AML)

United States
Sanofi

Completed

European Study of Dronedarone in Atrial Fibrillation (ERATO)

Atrial Fibrillation

France, Poland, Italy, Netherlands, Spain, Sweden, Switzerland, Belgium, Czech Republic
University of Florence

Completed

Use of G-CSF for the Treatment of Unexplained Recurrent Miscarriage

Habitual Abortion

Italy
AbbVie

Completed

RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)

Wet Macular Degeneration | Neovascular Age-related Macular Degeneration | Wet Age-related Macular Degeneration

United States
Caliway Biopharmaceuticals Co., Ltd.

Completed

A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers

Subcutaneous Fat

United States
Nektar Therapeutics

Completed

A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors (NKTR-214)

Unspecified Adult Solid Tumor, Protocol Specific

United States
Abbott Medical Devices

Completed

AVJ-514 Japan Trial

Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Functional Mitral Regurgitation | Mitral Stenosis With Insufficiency

Japan
Placon Therapeutics

Unknown

A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations

Breast Neoplasms | Prostatic Neoplasms | Pancreatic Neoplasms | Ovarian Neoplasms

United States
Aalborg University Hospital
Turku University Hospital; Oslo University Hospital; Helsinki University Central... and other collaborators

Terminated

Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma (SCF980266)

Malignant Lymphoma

Denmark, Sweden, Finland, Norway
Medical University of Vienna

Unknown

Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG

Coronary Artery Disease | Aorto-coronary Bypass Grafting

Austria
University of Rochester
National Institute on Aging (NIA)

Completed

Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II

Cognitive Impairment | Cancer-related Problem/Condition

United States
ou tongwen

Unknown

Measurement of Renal Functional Reserve Change In Patients With SRC Before and After Laparoscopic Deroofing

Simple Renal Cyst

China
Rennes University Hospital

Terminated

Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study (THERA)

Refractory Hemochromatosis Rheumatism

France
ElectroCore INC

Completed

A Randomized, Single Centre, Double-blind, Parallel, Sham-controlled Pilot Study Using gammaCore®-G

Dyspepsia | Irritable Bowel Syndrome

United Kingdom
Nantes University Hospital

Terminated

Effects (Long Term Analysis) of an Hyperproteinic Nutrition on Neonates With Intra-uterine Growth Delay : a Prospective, Multicentric , Randomized, Double Blind Study ("Proneonat") (Proneonat)

Intra-uterine Growth Delay

France
University Medical Center Groningen
University of Groningen

Completed

Group- Versus Individual-Mindfulness-Based Cognitive Therapy: a Randomized Trial (G/I-MBCT)

Depressive Symptoms
Pfizer

Completed

A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood After Dosing With Oral Inhalation From Dry Powder Inhalers

Pharmacokinetics

Singapore
Xeris Pharmaceuticals
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Emissary...

Completed

Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia

Hypoglycemia

United States
University Hospital Inselspital, Berne

Completed

Peg-Granulocyte-Colony Stimulating Factor (GCSF) for Coronary Collateral Growth in Coronary Artery Disease Patients

Coronary Artery Disease

Switzerland
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Combined Alcohol and Nitrous Oxide Intake - 15

Substance-Related Disorders | Opioid-Related Disorders

United States
Caliway Biopharmaceuticals Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease Lipomas

Dercum's Disease

United States
University of Alabama at Birmingham
University of North Carolina, Chapel Hill

Recruiting

Postpartum Glycemia in Women at Risk For Persistent Hyperglycemia

Gestational Diabetes

United States
Nanjing Yoko Biomedical Co., Ltd.

Recruiting

A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

Diffuse Large B-Cell Lymphoma, Unspecified Site

China
Washington University School of Medicine

Active, not recruiting

Defining Predictors of RT Response to Vedolizumab in IBD

Crohn Disease of Small Intestine

United States
University of Bologna

Completed

Diet and Plant Sterols in the Control of Cholesterolemia (DESCO) (DESCO)

Hypercholesterolemia

Italy
Emzor Pharmaceutical Industries Limited

Unknown

Bioequivalence Study of Sulfadoxine/ Pyrimethamine Tablets in Healthy Subjects Under Fasting Conditions

Bioequivalence
University of Sao Paulo

Completed

Creatine Supplementation and Bone Mass

Osteoporosis | Osteopenia

Brazil
University Hospital, Lille
Ministry of Health, France; French Health Products Safety Agency

Terminated

Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery (TRACES)

Hemorrhage | Pregnancy Complications

France
Mitsubishi Tanabe Pharma Corporation

Completed

A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia

Schizophrenia

Japan
Parc de Salut Mar
World Anti-Doping Agency

Completed

Dose-response Effect of Alcohol Ingestion on Steroid Profile (PROFETHYL/2)

Healthy | Alcohol Consumption

Spain
Yonsei University

Recruiting

Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury

Cerebral Palsy | Ischemic Stroke | Neurological Diseases | Hemorrhagic Stroke | Atypical Parkinson Disease

Korea, Republic of

Search clinical trials for: (G) BQ-L14

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations